An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials (Q43046357)

From Wikidata
Jump to navigation Jump to search
scientific article published in June 2010
edit
Language Label Description Also known as
English
An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials
scientific article published in June 2010

    Statements

    An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials (English)
    0 references
    0 references
    0 references
    M Ligueros-Saylan
    J E Foley
    A Schweizer
    A Couturier
    W Kothny
    1 June 2010
    495-509

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit